
Bioreactors And Fermenters Market Report 2026
Global Outlook – By Type (Single Use Bioreactors, Multiple Use Bioreactors), By Process (Fed Batch, Continuous, Batch), By End User (Biopharmaceutical Companies, Beverage Companies, Contract Research Organization (CRO), Academic And Research Institutions) – Market Size, Trends, Strategies, and Forecast to 2035
Bioreactors And Fermenters Market Overview
• Bioreactors And Fermenters market size has reached to $4.69 billion in 2025 • Expected to grow to $8.44 billion in 2030 at a compound annual growth rate (CAGR) of 12.1% • Growth Driver: Biotechnology Investment Fuels Growth In The Bioreactors And Fermenters Market • Market Trend: Innovations In Bioreactor Remote Monitoring And Control Software Transforming The Biotechnology Industry • North America was the largest region in 2025 and Europe is the fastest growing region.What Is Covered Under Bioreactors And Fermenters Market?
Bioreactors and fermenters are specialized systems used in biotechnology and industrial processes for the cultivation and growth of microorganisms, cells, or tissues by providing a controlled environment. These are used in the development and optimization of bioprocesses for the production of bio-based products. A bioreactor is a vessel developed for growing microorganisms or cells under controlled conditions for biotechnological processes, while a fermenter is a type of bioreactor specifically designed for microbial fermentation and used to produce enzymes, antibiotics, and biofuels. The main types of bioreactors and fermenters are single-use bioreactors and multiple-use bioreactors. Single-use bioreactors, also known as disposable bioreactors or disposable reactors, are a type of bioreactor used in the biotechnology and pharmaceutical industries for the cultivation of cells or microorganisms. Various processes are used, including fed-batch, continuous, and batch, which are used by several end users, such as biopharmaceutical companies, beverage companies, contract research organizations (CROs), and academic and research institutions.
What Is The Bioreactors And Fermenters Market Size and Share 2026?
The bioreactors and fermenters market size has grown rapidly in recent years. It will grow from $4.69 billion in 2025 to $5.35 billion in 2026 at a compound annual growth rate (CAGR) of 14.2%. The growth in the historic period can be attributed to expansion of biopharmaceutical manufacturing capacity, increasing use of microbial fermentation processes, growth in academic and research bioprocess studies, rising demand for biologics production, improvements in stainless steel bioreactor design.What Is The Bioreactors And Fermenters Market Growth Forecast?
The bioreactors and fermenters market size is expected to see rapid growth in the next few years. It will grow to $8.44 billion in 2030 at a compound annual growth rate (CAGR) of 12.1%. The growth in the forecast period can be attributed to increasing investments in biologics and biosimilars, rising adoption of continuous manufacturing, expansion of cell and gene therapy production, growing focus on flexible bioprocessing facilities, increasing demand for cost-efficient bioreactor systems. Major trends in the forecast period include increasing adoption of single-use bioreactor systems, rising demand for scalable bioprocessing platforms, growing integration of automated process controls, expansion of continuous bioprocessing methods, enhanced focus on contamination control and sterility.Global Bioreactors And Fermenters Market Segmentation
1) By Type: Single Use Bioreactors, Multiple Use Bioreactors 2) By Process: Fed Batch, Continuous, Batch 3) By End User: Biopharmaceutical Companies, Beverage Companies, Contract Research Organization (CRO), Academic And Research Institutions Subsegments: 1) By Single-Use Bioreactors: Disposable Bioreactors, Pre-Sterilized Bioreactors, Integrated Single-Use Systems 2) By Multiple-Use Bioreactors: Glass Bioreactors, Stainless Steel Bioreactors, Hybrid BioreactorsWhat Is The Driver Of The Bioreactors And Fermenters Market?
Increasing biotechnology investment is expected to propel the growth of the bioreactors and fermenters market going forward. Biotechnology investment refers to allocating financial resources, such as capital or funding, into companies, projects, or ventures within the biotechnology industry. Investments in biotechnology are increasing due to the growing demand for innovative healthcare solutions and advancements in genetic engineering. Biotechnology investment, which is essential for advancing biotechnological processes and accelerating biopharmaceutical production, provides funding for R&D activities focused on improving bioreactor and fermenter technologies. It also supports the scale-up and commercialization of bioreactor and fermenter technologies, facilitating their adoption in industrial biomanufacturing settings. For instance, in August 2024, according to the UK Biotech Financing Report published by the BioIndustry Association (BIA), a UK-based trade organization, the UK biotech sector witnessed substantial financial backing, in the UK, biotechnology investment has surged, with the sector raising $2.49 billion (£1.98 billion) in Q1 and Q2 2024, surpassing the $2.25 billion (£1.80 billion) raised throughout the entire year of 2023. Therefore, the increasing biotechnology investment is driving the growth of the bioreactors and fermenters industry.What Is The Driver Of The Bioreactors And Fermenters Market?
Increasing biotechnology investment is expected to propel the growth of the bioreactors and fermenters market going forward. Biotechnology investment refers to allocating financial resources, such as capital or funding, into companies, projects, or ventures within the biotechnology industry. Investments in biotechnology are increasing due to the growing demand for innovative healthcare solutions and advancements in genetic engineering. Biotechnology investment, which is essential for advancing biotechnological processes and accelerating biopharmaceutical production, provides funding for R&D activities focused on improving bioreactor and fermenter technologies. It also supports the scale-up and commercialization of bioreactor and fermenter technologies, facilitating their adoption in industrial biomanufacturing settings. For instance, in August 2024, according to the UK Biotech Financing Report published by the BioIndustry Association (BIA), a UK-based trade organization, the UK biotech sector witnessed substantial financial backing, in the UK, biotechnology investment has surged, with the sector raising $2.49 billion (£1.98 billion) in Q1 and Q2 2024, surpassing the $2.25 billion (£1.80 billion) raised throughout the entire year of 2023. Therefore, the increasing biotechnology investment is driving the growth of the bioreactors and fermenters industry.Global Bioreactors And Fermenters Market Trends and Insights
Major companies operating in the bioreactors and fermenters market are developing innovative technological solutions, such as Next-Gen bioreactor remote monitoring and control software, to increase their profitability in this market. Bioreactor remote monitoring and control software refers to specialized computer programs or systems that are designed to monitor, manage, and control bioreactors and fermenters from a centralized location, often through computer networks or the internet. For instance, in November 2023, The Cultivated B GmbH, a Germany-based biotechnology company, launched AUXO V, an innovative software that enables a real-time, application-based, personalized user interface with added remote accessibility for its AUXO V bioreactors. This next-generation bioreactor remote monitoring and control software provides a user-friendly system with real-time monitoring and personalized interfaces accessible remotely via phone and web-based platforms. The software allows for direct or remote control of bioprocesses, 24/7 monitoring for rapid intervention, and automated processes to optimize workforce allocation.What Are Latest Mergers And Acquisitions In The Bioreactors And Fermenters Market?
In August 2024, Zydus Lifesciences Limited, an India-based pharmaceutical company, acquires a 50% stake in Sterling Biotech Ltd. for an undisclosed amount. The joint venture aims to establish a cutting-edge facility for manufacturing fermented animal-free protein targeted at global markets. Sterling Biotech Ltd. is an India-based biotechnology company that specializes in developing innovative fermentation technologies.Regional Outlook
North America was the largest region in the bioreactors and fermenters market in 2025. Europe is expected to be the fastest-growing region in the forecast period. The regions covered in this market report are Asia-Pacific, South East Asia, Western Europe, Eastern Europe, North America, South America, Middle East and Africa. The countries covered in this market report are Australia, Brazil, China, France, Germany, India, Indonesia, Japan, Taiwan, Russia, South Korea, UK, USA, Italy, Spain, CanadaWhat Defines the Bioreactors And Fermenters Market?
The bioreactors and fermenters market consists of sales of stirred-tank bioreactors, batch bioreactors, stirred-tank bioreactors, photobioreactors, and anaerobic fermenters. Values in this market are ‘factory gate’ values, that is the value of goods sold by the manufacturers or creators of the goods, whether to other entities (including downstream manufacturers, wholesalers, distributors and retailers) or directly to end customers. The value of goods in this market includes related services sold by the creators of the goods.How is Market Value Defined and Measured?
The market value is defined as the revenues that enterprises gain from the sale of goods and/or services within the specified market and geography through sales, grants, or donations in terms of the currency (in USD unless otherwise specified). The revenues for a specified geography are consumption values that are revenues generated by organizations in the specified geography within the market, irrespective of where they are produced. It does not include revenues from resales along the supply chain, either further along the supply chain or as part of other products.What Key Data and Analysis Are Included in the Bioreactors And Fermenters Market Report 2026?
The bioreactors and fermenters market research report is one of a series of new reports from The Business Research Company that provides market statistics, including industry global market size, regional shares, competitors with the market share, detailed market segments, market trends and opportunities, and any further data you may need to thrive in the bioreactors and fermenters industry. The market research report delivers a complete perspective of everything you need, with an in-depth analysis of the current and future state of the industry.Bioreactors And Fermenters Market Report Forecast Analysis
| Report Attribute | Details |
|---|---|
| Market Size Value In 2026 | $5.35 billion |
| Revenue Forecast In 2035 | $8.44 billion |
| Growth Rate | CAGR of 14.2% from 2026 to 2035 |
| Base Year For Estimation | 2025 |
| Actual Estimates/Historical Data | 2020-2025 |
| Forecast Period | 2026 - 2030 - 2035 |
| Market Representation | Revenue in USD Billion and CAGR from 2026 to 2035 |
| Segments Covered | Type, Process, End User |
| Regional Scope | Asia-Pacific, Western Europe, Eastern Europe, North America, South America, Middle East, Africa |
| Country Scope | The countries covered in the report are Australia, Brazil, China, France, Germany, India, ... |
| Key Companies Profiled | Thermo Fisher Scientific Inc, Sartorius AG, Danaher Corporation, GE Healthcare, Eppendorf AG, Getinge AB, ZETA Holding, Pierre Guerin SAS, Parr Instrument Company, PBS Biotech, Bioengineering AG, Finesse Solutions, Infors AG, Synthecon Inc, Cellexus Ltd, Scigenics Pvt Ltd, Shanghai Bailun Biological Technology, Zhengzhou Laboao Instrument Equipment, Solaris Biotechnology Srl, Electrolab Biotech Ltd, BBI Biotech GmbH, Distek Inc |
| Customization Scope | Request for Customization |
| Pricing And Purchase Options | Explore Purchase Options |
